Picton Mahoney Asset Management’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-249,996
Closed -$2.49M 829
2022
Q3
$2.49M Hold
249,996
0.09% 252
2022
Q2
$2.47M Hold
249,996
0.09% 321
2022
Q1
$2.46M Buy
249,996
+150,000
+150% +$1.47M 0.09% 327
2021
Q4
$974K Hold
99,996
0.02% 592
2021
Q3
$979K Hold
99,996
0.04% 519
2021
Q2
$976K Buy
+99,996
New +$987K 0.03% 550

Picton Mahoney Asset Management's FLAC Position: Q4 2022 in Review

Picton Mahoney Asset Management sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 249,996 shares — an estimated $2.49M sold.

Picton Mahoney Asset Management first reported a position in FLAC in Q2 2021 and held it in 6 quarters. The position peaked at $2.49M in Q3 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

  • Picton Mahoney Asset Management reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 249,996 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $2.49M.
  • Picton Mahoney Asset Management first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q2 2021 and held it in 6 quarters.
  • Picton Mahoney Asset Management's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $2.49M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on Picton Mahoney Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.